Cipher Pharmaceuticals Inc.
CPH.TO
TSX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 5.89M | 2.62M | 3.34M | 283.00K | 3.00M |
Total Depreciation and Amortization | 1.81M | 1.82M | 1.51M | 1.93M | 292.00K |
Total Amortization of Deferred Charges | 37.00K | 38.00K | 39.00K | 22.00K | -- |
Total Other Non-Cash Items | -803.00K | -494.00K | -4.08M | 20.00K | 110.00K |
Change in Net Operating Assets | -914.00K | 230.00K | 8.07M | -248.00K | 2.83M |
Cash from Operations | 6.02M | 4.22M | 8.89M | 2.00M | 6.23M |
Capital Expenditure | 0.00 | -2.00K | -7.00K | -80.02M | -11.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | 0.00 | -2.00K | -7.00K | -80.02M | -11.00K |
Total Debt Issued | -- | -- | 0.00 | 40.00M | -- |
Total Debt Repaid | -15.08M | -76.00K | -70.00K | -106.00K | -29.00K |
Issuance of Common Stock | 10.00K | 31.00K | 15.00K | 10.00K | 24.00K |
Repurchase of Common Stock | -2.14M | -- | 0.00 | 0.00 | 0.00 |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -49.00K | -398.00K | -- |
Cash from Financing | -17.21M | -45.00K | -104.00K | 39.51M | -5.00K |
Foreign Exchange rate Adjustments | 530.00K | -10.00K | -461.00K | 52.00K | -206.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -10.66M | 4.16M | 8.31M | -38.46M | 6.00M |